compounding pharmacies

News

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

News

Noom Med app and accompanying GLP-1 implements

Noom expands its GLP-1 range with 'microdose' package

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

News

Novo Nordisk asks FDA not to allow GLP-1 compounding

Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

News

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made

FDA lends a hand to Novo, Lilly on illegal GLP-1 imports

Noom expands its GLP-1 range with 'microdose' package

Compounders cast adrift after semaglutide shortage ends

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Novo Nordisk asks FDA not to allow GLP-1 compounding

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

compounding pharmacies

Editor's Picks